Green and sustainable approaches for the Friedel–Crafts reaction between aldehydes and indoles

• Periklis X. Kolagkis,
• Eirini M. Galathri and
• Christoforos G. Kokotos

Beilstein J. Org. Chem. 2024, 20, 379–426, doi:10.3762/bjoc.20.36

• number of inflammatory processes, which can lead to inflammatory bowel disease or Alzheimer’s disease. Therefore, GPR84 agonists are used as medicine for the treatment of various inflammatory diseases, but they have been also linked to the reduction of leukemia cells, since the continuous expression of

Cholyl 1,3,4-oxadiazole hybrid compounds: design, synthesis and antimicrobial assessment

• Anas J. Rasras,
• Mohamed El-Naggar,
• Nesreen A. Safwat and
• Raed A. Al-Qawasmeh

Beilstein J. Org. Chem. 2022, 18, 631–638, doi:10.3762/bjoc.18.63

• enhanced the biological activities like anticancer [15][16], antibacterial [17], antimalarial [18], anti-inflammatory [19], and lead to a promising scaffold for the treatment of Alzheimer’s disease [20]. Our previous work showed that a combination between cholic acid and heterocyclic scaffolds improved the

Synthesis of sulfur karrikin bioisosteres as potential neuroprotectives

• Martin Pošta,
• Václav Zima,
• Lenka Poštová Slavětínská,
• Marika Matoušová and
• Petr Beier

Beilstein J. Org. Chem. 2022, 18, 549–554, doi:10.3762/bjoc.18.57

• brain of patients suffering with the Parkinson’s and the Alzheimer’s disease, respectively. Therefore, research is focused on the discovery of new drugs protecting acetylcholine and dopamine levels via inhibition of acetylcholinesterase (AChE) and monoamine oxidase (MAO). A promising source of such

Synthesis of new substituted 7,12-dihydro-6,12-methanodibenzo[c,f]azocine-5-carboxylic acids containing a tetracyclic tetrahydroisoquinoline core structure

• Agnieszka Grajewska,
• Maria Chrzanowska and
• Wiktoria Adamska

Beilstein J. Org. Chem. 2021, 17, 2511–2519, doi:10.3762/bjoc.17.168

• promising for the treatment of nervous system disorders, such as Parkinson’s and Alzheimer’s disease [6][7]. Hanessian and co-workers designed isopavines of type III (Figure 1) that act as morphinomimethics and bind strongly to human opioid receptors [8][9]. The synthesis of these compounds involved the

Catalyzed and uncatalyzed procedures for the syntheses of isomeric covalent multi-indolyl hetero non-metallides: an account

• Ranadeep Talukdar

Beilstein J. Org. Chem. 2021, 17, 2102–2122, doi:10.3762/bjoc.17.137

• the strong base led to the formation of the over-aminated product 168 (Scheme 22b) [110]. Alzheimer’s disease is caused by the β-amyloid-42 aggregation in brain tissue [111][112]. In 2017, Sreenivasachary synthesized a library of 6,5’- and 6,6’-bis(indolyl)amines and other similar 7-azaindole

Asymmetric organocatalyzed synthesis of coumarin derivatives

• Natália M. Moreira,
• Lorena S. R. Martelli and
• Arlene G. Corrêa

Beilstein J. Org. Chem. 2021, 17, 1952–1980, doi:10.3762/bjoc.17.128

• long-acting vitamin K antagonist (Figure 1) [8]. This scaffold has also been reported as anti-Alzheimer’s disease [9], such as the natural product decursinol, isolated from Angelica gigas [10]. In this sense, our research group has synthesized and evaluated a library of coumarin derivatives as

On the application of 3d metals for C–H activation toward bioactive compounds: The key step for the synthesis of silver bullets

• Renato L. Carvalho,
• Amanda S. de Miranda,
• Mateus P. Nunes,
• Roberto S. Gomes,
• Guilherme A. M. Jardim and
• Eufrânio N. da Silva Júnior

Beilstein J. Org. Chem. 2021, 17, 1849–1938, doi:10.3762/bjoc.17.126

• high importance in the field of Alzheimer’s disease studies [169]. In 2020, Xu and co-workers described an unprecedented dual C–H functionalization of indolin-2-ones and benzofuran-2-ones via an oxidative C(sp3)–H cross-coupling protocol catalyzed by inexpensive FeCl3 and ligand-free conditions (Scheme

Sustainable manganese catalysis for late-stage C–H functionalization of bioactive structural motifs

• Jongwoo Son

Beilstein J. Org. Chem. 2021, 17, 1733–1751, doi:10.3762/bjoc.17.122

• combination of a manganese catalyst and a electrophotocatalyst for the late-stage Csp3–H azidation of biologically active molecules in a selective and sustainable manner (Scheme 4) [40]. Memantine is a drug used to treat neurodegenerative disorders such as Alzheimer’s disease [41][42]. In the authors’ study

N-tert-Butanesulfinyl imines in the asymmetric synthesis of nitrogen-containing heterocycles

• Joseane A. Mendes,
• Paulo R. R. Costa,
• Miguel Yus,
• Francisco Foubelo and
• Camilla D. Buarque

Beilstein J. Org. Chem. 2021, 17, 1096–1140, doi:10.3762/bjoc.17.86

• interest for the treatment of Alzheimer’s disease and other neurological disorders (Scheme 37). The diastereoselective synthesis of trans-5-hydroxy-6-substituted 2-piperidinones 139 was also achieved from O-benzyl protected aldimine 138 following the previously commented tandem Grignard reagent addition

Stereoselective synthesis and transformation of pinane-based 2-amino-1,3-diols

• Ákos Bajtel,
• Mounir Raji,
• Matti Haukka,
• Ferenc Fülöp and
• Zsolt Szakonyi

Beilstein J. Org. Chem. 2021, 17, 983–990, doi:10.3762/bjoc.17.80

• very good agonist for the S1P1 receptor (Figure 1). Sphingosine 1-phosphate (S1P, 4), in turn, performed critical regulator functions in many physiological and pathological treatments, such as Alzheimer’s disease [8][9], cancer [10][11][12][13], multiple sclerosis [14], and inflammation [15]. Due to

Microwave-assisted multicomponent reactions in heterocyclic chemistry and mechanistic aspects

• Shivani Gulati,
• Stephy Elza John and
• Nagula Shankaraiah

Beilstein J. Org. Chem. 2021, 17, 819–865, doi:10.3762/bjoc.17.71

• . Tacrine (1) is an acridine derivative used in the treatment of Alzheimer’s disease. A plethora of acridine derivatives have been synthesized and clinically proved with various biological activities such as ethacridine (antibacterial drug; 2), acranil (antiviral drug; 3) and quinacrine (antimalarial agent

Simulating the enzymes of ganglioside biosynthesis with Glycologue

• Andrew G. McDonald and
• Gavin P. Davey

Beilstein J. Org. Chem. 2021, 17, 739–748, doi:10.3762/bjoc.17.64

• gangliosides, such as GD1α, promote tumor-cell adhesion during metastasis [13]. The cholinergic neuron-specific gangliosides GQ1bα and GT1aα may contribute to the pathogenesis of Alzheimer’s disease [14]. Previously, we described a deductive apparatus of a formal system for modelling the enzymes of mucin-type

• derivatives of the GM1a with terminal sialylation, GD1a, GT1a [28], and GQ1a. The b-series gangliosides, GD1b, GT1b (both downregulated in Alzheimer’s disease [14][29]), GQ1b and GP1b, and their three α-variants are predicted. There is no GT1bα, since a terminal sialic acid on position IV is required by

¹⁹F NMR as a tool in chemical biology

• Diana Gimenez,
• Aoife Phelan,
• Cormac D. Murphy and
• Steven L. Cobb

Beilstein J. Org. Chem. 2021, 17, 293–318, doi:10.3762/bjoc.17.28

• fibril formation, enabling the elucidation of the underlying mechanics of peptide fibrillation. To study the aggregation mechanism of the model Aβ-peptide, a well-known amyloidogenic peptide related to Alzheimer’s disease, Marsh and collaborators synthesized a 19F-labelled Aβ1−40 peptide version in which

Vicinal difluorination as a C=C surrogate: an analog of piperine with enhanced solubility, photostability, and acetylcholinesterase inhibitory activity

• Yuvixza Lizarme-Salas,
• Alexandra Daryl Ariawan,
• Ranjala Ratnayake,
• Hendrik Luesch,
• Angela Finch and
• Luke Hunter

Beilstein J. Org. Chem. 2020, 16, 2663–2670, doi:10.3762/bjoc.16.216

• dual mechanism-of-action treatment for Alzheimer’s disease [4][10][11][12][13]. However, piperine (1) has some limitations as a drug lead. For example, it has poor solubility, and it is susceptible to photoisomerization of the conjugated system [15][16][17]. This prompted us to consider whether there

• was another structural motif that could (i) mimic the extended geometry of an E-alkene, (ii) impart better solubility, and (iii) be more stable in the presence of UV light. Such a C=C surrogate might offer an improved lead compound for the development of drugs to treat Alzheimer’s disease

• purpose of treating Alzheimer’s disease, it should be noted that problems have been encountered in clinical trials with BACE-1 as the target [36], suggesting that the analog 2 might still have relevance in the context of an Alzheimer’s treatment. More generally, our finding that the threo-difluoroalkane

NMR Spectroscopy of supramolecular chemistry on protein surfaces

• Peter Bayer,
• Anja Matena and
• Christine Beuck

Beilstein J. Org. Chem. 2020, 16, 2505–2522, doi:10.3762/bjoc.16.203

• amino acid residues is an elegant way to circumvent the aforementioned challenges. The supramolecular tweezers have been shown to inhibit amyloid fibril formation of the 441 residue full-length tau protein [81], which is one of the relevant culprits in Alzheimer’s disease and other tauopathies. Specific

Synthesis of 1,4-benzothiazinones from acylpyruvic acids or furan-2,3-diones and o-aminothiophenol

• Ekaterina E. Stepanova,
• Maksim V. Dmitriev and
• Andrey N. Maslivets

Beilstein J. Org. Chem. 2020, 16, 2322–2331, doi:10.3762/bjoc.16.193

• use. Particularly, some enaminones I and II were found to show antioxidant [3], antimycotic [7][8], antimycobacterial [9][10], anti-Alzheimer’s disease (JNK3 inhibitors) [11], platelet aggregation inhibitory [12], antimicrobial [7] and analgesic [13] activities. Enaminones II were reported as

Recent advances in Cu-catalyzed C(sp³)–Si and C(sp³)–B bond formation

• Balaram S. Takale,
• Ruchita R. Thakore,
• Elham Etemadi-Davan and
• Bruce H. Lipshutz

Beilstein J. Org. Chem. 2020, 16, 691–737, doi:10.3762/bjoc.16.67

• . Interestingly, this protocol was applied to the total synthesis of (R)-oxiracetam (142), a drug used for the treatment of Alzheimer’s disease [61]. In a similar way, a ligand-free, intramolecular silylarylation of unsaturated amides 143 could be performed, albeit following a radical pathway leading to cyclic

An improved, scalable synthesis of Notum inhibitor LP-922056 using 1-chloro-1,2-benziodoxol-3-one as a superior electrophilic chlorinating agent

• Nicky J. Willis,
• Elliott D. Bayle,
• George Papageorgiou,
• David Steadman,
• Benjamin N. Atkinson,
• William Mahy and
• Paul V. Fish

Beilstein J. Org. Chem. 2019, 15, 2790–2797, doi:10.3762/bjoc.15.271

• signalling pathway has been shown to regulate crucial aspects of cell fate determination, organogenesis, cell migration and polarity [1]. Importantly, compromised Wnt signalling has been implicated in the perturbation of synaptic integrity and function in Alzheimer’s disease (AD) [2]. Palmitoleoylation of

Synthesis of 3-aminocoumarin-N-benzylpyridinium conjugates with nanomolar inhibitory activity against acetylcholinesterase

• Nisachon Khunnawutmanotham,
• Cherdchai Laongthipparos,
• Patchreenart Saparpakorn,
• Nitirat Chimnoi and
• Supanna Techasakul

Beilstein J. Org. Chem. 2018, 14, 2545–2552, doi:10.3762/bjoc.14.231

• -related health issues, such as arthritis, heart disease, cancer, diabetes and Alzheimer’s disease, all of which can potentially decrease the quality of life. Dementia, commonly found among the elderly, can be caused by the Alzheimer’s disease (AD) – a progressive neurodegenerative disorder. The

Synthesis of dihydroquinazolines from 2-aminobenzylamine: N³-aryl derivatives with electron-withdrawing groups

• Nadia Gruber,
• Jimena E. Díaz and
• Liliana R. Orelli

Beilstein J. Org. Chem. 2018, 14, 2510–2519, doi:10.3762/bjoc.14.227

• ][10][11], as tumor suppressors [12] and as neuroprotective agents has also been reported [13]. Some related 2-amino-DHQs were studied as blood platelet aggregation inhibitors [14], antihypertensive agents [15] or inhibitors of β-secretase, an important target for Alzheimer’s disease [16]. Additionally

Recent applications of click chemistry for the functionalization of gold nanoparticles and their conversion to glyco-gold nanoparticles

• Vivek Poonthiyil,
• Thisbe K. Lindhorst,
• Vladimir B. Golovko and
• Antony J. Fairbanks

Beilstein J. Org. Chem. 2018, 14, 11–24, doi:10.3762/bjoc.14.2

• system was then used for the detection of amyloid-β peptides [74], whose aggregation is responsible for Alzheimer’s disease [75]. In 2014, Fairbanks and co-workers reported a one-pot aqueous compatible method for making various triazole-linked glycoconjugates via intermediate glycosyl azides, which then

The use of 4,4,4-trifluorothreonine to stabilize extended peptide structures and mimic β-strands

• Yaochun Xu,
• Isabelle Correia,
• Tap Ha-Duong,
• Nadjib Kihal,
• Jean-Louis Soulier,
• Julia Kaffy,
• Benoît Crousse,
• Olivier Lequin and
• Sandrine Ongeri

Beilstein J. Org. Chem. 2017, 13, 2842–2853, doi:10.3762/bjoc.13.276

• extended conformations. Inhibition of Aβ1-42 fibrillization. In the frame of our interest in modulators of protein–protein interactions involving β–sheet structures, in particular in the field of Aβ1-42 peptide aggregation involved in Alzheimer’s disease [15][39][40][41][42], we evaluated the activity of

Solid-state studies and antioxidant properties of the γ-cyclodextrin·fisetin inclusion compound

• Joana M. Pais,
• Maria João Barroca,
• Maria Paula M. Marques,
• Filipe A. Almeida Paz and
• Susana S. Braga

Beilstein J. Org. Chem. 2017, 13, 2138–2145, doi:10.3762/bjoc.13.212

• reducing complications associated with type I diabetes [14] and features, upon oral administration, neuroprotective and memory-enhancing properties [15][16]. For this reason, fisetin is being proposed as a new approach to treat Alzheimer’s disease [17]. However, fisetin is practically insoluble in water

Oxidative dehydrogenation of C–C and C–N bonds: A convenient approach to access diverse (dihydro)heteroaromatic compounds

• Santanu Hati,
• Ulrike Holzgrabe and
• Subhabrata Sen

Beilstein J. Org. Chem. 2017, 13, 1670–1692, doi:10.3762/bjoc.13.162

• pharmaceutical ingredients. The following section will describe a few of such efforts. In 2013, Witt et al. reported a scalable process for the synthesis of GSK3B inhibitor AZD8926, 103 [99]. The drug is therapeutically useful for the treatment of CNS disorder viz. Alzheimer’s disease (AD), Schizophrenia and

Syntheses of 3,4- and 1,4-dihydroquinazolines from 2-aminobenzylamine

• Jimena E. Díaz,
• Silvia Ranieri,
• Nadia Gruber and
• Liliana R. Orelli

Beilstein J. Org. Chem. 2017, 13, 1470–1477, doi:10.3762/bjoc.13.145

• important target for Alzheimer’s disease) has been reported [16]. They have also been studied as inhibitors of trypanothione reductase [17], an essential enzyme of the parasite Trypanosoma brucei, and as neuroprotective agents [18]. Different strategies have been used for the preparation of